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AneuploidyAbstract Background: Down syndrome, the most common trisomy 21 arises from abnormal
chromosomal segregation. The etiology includes genetic and acquired factors. The main genetic fac-
tor that is well appreciated for onset of Down syndrome pregnancy isMTHFR gene polymorphism.
But till date, no ﬁnal conclusion has arrived despite multiple studies on this gene polymorphism.
Aim: To investigate the risk of MTHFR gene polymorphisms, C677T and A1298C, with Down
syndrome pregnancies and a meta-analysis of published literature.
Subjects and methodology: PCR-RFLP method was used to genotype C677T and A1298C poly-
morphism. For meta-analysis the literature was retrieved from PubMed database with the key
words, MTHFR polymorphism; C677T; A1298C and Down syndrome.
Results: Mothers carrying C677T polymorphism had a risk of 2.48 times compared with control
subjects while A1298C polymorphism carriers had 1.60 times and 2.12 times increased risk under
assumption of dominant and recessive model. However, meta-analysis of published studies resulted
in 1.26 times and 1.32 times increased risk of Down syndrome pregnancies among the C677T carries
under the assumption of recessive anddominantmodels of inheritance. ConsideringA1298Cpolymor-
phism, dominant model predicated no risk; recessive model resulted in 1.34 times increased risk in CC
genotype individuals. In subgroupanalysis, Indian studies had a risk of 1.61 times and 1.44 times under
recessive and dominantmodel of C677T polymorphism inheritance while A1298C polymorphism car-
riers had a risk of 1.75 and 1.46 under the assumption of recessive and dominant inheritance.
Conclusion: Our study suggests that both C677T and A1298C polymorphisms are signiﬁcantly
associated with the risk of DS pregnancy.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).steine to
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Table 1 Frequency of MTHFR C677T and A1298C poly-
morphism in study subjects.
Genotype/Allele Cases
(n= 87)
Controls
(n= 110)
Odds ratio (CI)
C677T Polymorphism (in %)
CC 51.8 72.7 1
CT 48.2 27.3 2.48 (1.37–4.5)
TT 0 0 P= 0.0025
C 75.9 86.4
T 24.1 13.6
A1298C Polymorphism (in %)
AA 36.8 48.2 1
AC 50.5 45.5 1.60 (0.89–2.83)*@
CC 12.7 6.3 2.12 (0.79–5.75)*#
A 62 71
C 38 29
* Statistically not signiﬁcant.
@ AA Vs AC+CC.
# AA+AC Vs CC.
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Down syndrome (DS) is the most common trisomy in live born
with a prevalence of 1 in 1000 to 1 in 1100 (WHO report,
http://www.who.int/genomics/public/geneticdiseases/en/index1.
html). It is characterized by the presence and expression of
three copies of chromosome 21. The extra copy arises from
abnormal segregation during meiosis [1–3,22]. Meiotic nondis-
junction is attributed to multifactorial etiology-genetic and
acquired factors; well-studied etiologies were maternal age
and genetic polymorphism of folate metabolic pathway. How-
ever, recent studies reported that DS children are born to
mothers of age lesser than 25 years [4].
Thirty four years of extensive research into folate metabo-
lism pathway has instanced its indispensable function in
almost all cellular process, nucleotide synthesis, amino acid
synthesis and synthesis of S-adenosyl methionine, DNA and
lipid methylation reactions [5].
Folate metabolism is governed by multiple enzymes:
methylenetetrahydrofolate reductase (MTHFR), converts
5,10-methylenetetrahydrofolate to 5 methylenetetrahydrofo-
late; methionine synthase (MTR), remethylation of homocys-
teine to methionine; methionine synthase reductase (MTRR),
regenerates methionine synthase; cystathionine beta-synthase
(CBS), transsulfuration of homocysteine to cystathionine;
and ﬁnally, folate transporting protein (RFC-1), transporting
5-methyltetrahydroﬂate into cells [6–10].
Various clinical as well as experimental evidences have
linked DNA hypomethylation to chromosomal instability
and aneuploidy, such examples are ICF syndrome and tumors
having DNA hypomethylation [2]. Genetic variants of these
enzymes are reported to modulate folate pathway; MTHFR-
C677T and A1298C polymorphisms remains as most com-
monly studied enzyme for their association with DS pregnancy
[2–4,11–13,18,22–24,28,29].
In-vitro studies have demonstrated that C677T nucleotide
transition modulates enzyme activity by approximately 50%
and the enzyme becomes thermolabile. Still, the enzyme activ-
ity can be retained by folate supplement [14,15]. The second
most common variant, A1298C (exon 7), point mutation
causes substitution of alanine in place of glutamate. Upon
mutation the activity of enzyme is reduced to 68% of the wild-
type enzyme. Though, the enzyme is not thermolabile and does
not appear to have higher serum homocysteine levels [16,17].
Yet, a clear reason for the association ofMTHFR polymor-
phism with DS pregnancies has to be ascertained. Various indi-
vidual studies have found an increased frequency of 677-TT
genotype in mothers of DS children compared to controls
along with elevated homocysteine and reduced methionine
levels [2,18]. Provided this background, it was hypothesized
that reduced MTHFR enzyme activity (C677T polymorphism)
will result in DNA hypomethylation at pericentromeric region
of chromosome. The hypomethylation might cause abnormal
chromosomal segregation, predisposing to trisomy 21 [2].
Alternative hypothesis supports the survival advantage of
CBS overexpression which counteracts the effect of MTHFR
variant in fetus thereby maintaining minimal supply of folate
for vital functions [18–21].
In light of the provided evidences linking MTHFR
polymorphisms to the DS pregnancies, many researchers are
testing the hypothesis that variability of the MTHFR genesequence might be a general mechanism predisposing women
to DS pregnancy [22–24,11–13,25,2,18]. However, the results
in the publications are in support [45,36,24,25,2] and against
this hypothesis [39,32,38,47,37]. Controversies may be due to
relatively small number of participants in individual studies
that is statically underpowered to detect the effect. Meta-
analysis is a powerful tool for summarizing the results from
multiple different studies by producing a single estimate of
the major effect with enhanced precision. In the present study,
therefore, we perform the current meta-analysis to examine
whether the MTHFR polymorphisms are associated with DS
pregnancies or not.
2. Subjects and methods
2.1. Study subjects
It was a hospital based case–control study conducted between
2012 and 2014. All the participants were of Indian origin. Case
cohort includes 87 mothers of individuals with DS-ascertained
by Quantitative ﬂuorescent PCR (QF-PCR), while control
cohort constitutes 110 mothers with no history of DS pregnan-
cies. 2 ml of venous blood samples were collected on EDTA
vial from all mothers and preserved at 4 C till analysis.
Genomic DNA was isolated from the samples by standard
phenol chloroform method; quality and quantity were assured
by agarose gel electrophoresis and Nanodrop reading. The study
was cleared by the institutional ethics committee. The work has
been carried out in accordance with The Code of Ethics of the
World Medical Association (Declaration of Helsinki).
2.2. Genotyping
MTHFR C677T genotyping [26] was performed by PCR
ampliﬁcation of target sequence of 203 bp in a reaction con-
taining 50 ng genomic DNA, 10 pmol each of forward primer
‘‘50-GCACTTGAAGGAGAAGGTGTC-30” and reverse
primer ‘‘50-AGGACGGTGCGGTGAGAGTG-30”, 1.5 mM
MgCl2, 200 lM each dNTPs and 1 unit Taq Polymerase
Table 2 Summary of included studies.
Study id Population Case/control no. C677T polymorphism A1298C polymorphism
Case Control HWE Case Control HWE
CC CT TT CC CT TT AA AC CC AA AC CC
Aca´cio [22] Brazil 70/88 35 30 5 54 25 9 0.03 30 37 3 50 32 6 0.77
Biselli [23] Brazil 72/194 29 35 8 100 77 17 0.69 40 27 5 108 74 12 0.88
Bodurog˘lu [24] Turkey 152/91 86 55 11 58 30 3 0.71 44 97 11 21 60 10 0.00
Brandalize [31] Brazil 239/197 94 113 32 86 93 18 0.31 143 84 12 113 76 8 0.27
Chango [32] French 119/119 43 64 12 49 58 12 0.38 59 49 11 52 56 12 0.58
Coppede [33] Italian 80/111 20 43 16 39 54 18 0.92 37 29 3 46 48 6 0.15
Coppede [34] Italy 94/113 25 52 17 40 55 18 0.90 44 38 6 43 53 7 0.08
Coppede [35] Italian 29/32 5 19 5 11 17 4 0.51 14 15 0 13 19 0 0.01
da [36] Brazil 154/158 67 72 15 84 67 7 0.15 99 49 6 101 50 7 0.79
Hobbs [18] Whites 157/144 51 84 22 67 59 14 0.84 0 0 0 0 0 0 0
James [2] 57/50 15 34 8 24 22 4 0.73 0 0 0 0 0 0 0
Kokotas [37] Danish 177/1084 92 72 13 545 449 90 0.85 0 0 0 0 0 0 0
Martinez-Frias [38] Spain 146/188 61 61 24 76 85 27 0.68 76 57 13 91 78 19 0.70
Meguid [25] Egyption 42/48 20 17 5 33 12 3 0.21 8 20 14 18 29 1 0.00
O’leary [39] Irish 48/192 18 21 2 90 84 18 0.80 0 0 0 0 0 0 0
Sadiq [40] Jordan 53/29 23 27 3 23 5 1 0.31 10 18 1 24 29 0 0.00
Santos-Reboucas [41] Brazil 103/108 51 43 9 49 47 12 0.88 58 40 5 57 49 2 0.01
Scala [42] Italy 94/264 31 39 24 74 125 57 0.75 38 39 17 128 108 25 0.74
Stuppia [43] Italy 64/112 20 32 12 27 62 23 0.25 0 0 0 0 0 0 0
Vranekovi´c [44] Caucasian 111/141 49 49 13 66 64 11 0.40 48 56 7 63 68 10 0.14
Wang [45] China 64/70 14 32 18 36 29 5 0.79 0 0 0 0 0 0 0
Zampieri [47] Brazil 105/185 40 55 10 94 73 18 0.49 51 48 6 101 73 9 0.36
Indian studies
Cyril [11] India 36/60 33 3 0 60 0 0 0 14 19 3 26 21 13 0.03
Kaur [13] India 110/111 86 22 2 89 22 0 0.24 0 0 0 0 0 0 0
Kohli [12] India 104/109 74 29 0 71 32 6 0.35 0 0 0 0 0 0 0
Mohanty [45] India 52/52 44 8 0 49 3 0 0.83 0 0 0 0 0 0 0
Rai [46] India 89/70 60 23 6 54 16 0 0.28 28 39 22 28 37 5 0.12
Present Study India 87/110 45 42 0 80 30 0 0.09 32 44 11 53 50 7 0.28
HWE-Hardy–Weinberg equilibrium of controls.
Table 3 Metaanalysis of C677T polymorphism and A1298C polymorphism.
Model Population Sample P heterogeneity Eﬀect model Test of association
Case Control OR (95% CI) P value
C677T Polymorphism
Recessive Others 2222 3706 0.67 Random 1.25 (1.05–1.50) 0.01*
Indian 477 512 0.04 1.61 (0.07–35.27) 0.76
Overall 2699 4218 0.45 1.26 (1.05–1.50) 0.01*
Dominant Others 2222 3706 0.006 Fixed 1.31 (1.17–1.46) <1  105*
Indian 477 512 0.03 1.44 (1.07–1.95) 0.02
Overall 2699 4218 0.002 1.32 (1.19–1.47) <1  105*
A1298C Polymorphism
Recessive Others 1406 1741 0.14 Fixed 1.25 (0.95–1.65) 0.12
Indian 212 240 0.01 1.75 (1.0–3.07) 0.54
Overall 1618 1981 0.02 1.34 (1.04–1.72) 0.02*
Dominant Others 1622 2065 0.36 Random 1.00 (0.87–1.14) 0.99
Indian 212 240 0.86 1.46 (0.99–2.14) 0.05*
Overall 1834 2305 0.34 1.04 (0.92–1.18) 0.53
* Statistical signiﬁcance.
The risk of MTHFR gene polymorphisms with Down syndrome pregnancies 89(Bangalore Genei, India) in a total volume of 50 ll. PCR
conditions were as follows: denaturation at 94 C for 5 min,
followed by 35 cycles at 94 C for 30 s, 55 C for 30 s, and72 C for 30 s; the terminal elongation was performed at
72 C for 5 mins. The PCR products were checked on 2%
agarose gel followed by restriction digestion of 10 ll of PCR
90 S. Muthuswamy, S. Agarwalproduct with 10 U of HinfI restriction enzyme (Newengland
biolabs, UK) and checked on 4% agarose gel (Wildtype:
203 bp, Variant allele: 173 bp + 30 bp).
A1298C genotyping [27] was carried out with the set of for-
ward ‘‘50-CTT TGG GGA GCT GAA GGA CTA CTA C-30”
and reverse ‘‘50-CAC TTT GTG ACC ATT CCG GTT TG-30”
primers. The reaction consisted of 50 ng genomic DNA,
10 pmol of each primer, 1.5 mM MgCl2, 200 lM each dNTP’s
and 1 U Taq polymerase (Bangalore Genei, India) in a total
volume of 50 ll. PCR proﬁle was similar to that of C677T
polymorphism. Ampliﬁed products (163 bp) were checked on
2% agarose gel. The PCR products (10 ll) were restriction
digested with 10 l of MboII enzyme and checked on 4% agar-
ose gel (Wildtype: 56, 31, 30, 28 and 18 bp, Variant allele: 84,
31, 30 and 18 bp).Figure 1 Results from meta-analysis of MTHFR C677T2.3. Literature search
Studies published before April 1st 2014 were identiﬁed through
a search on Pubmed and Web of Science databases using the
keywords ‘‘MTHFR polymorphism” or ‘‘C677T” or
‘‘A1298C” and DS. All references cited in retrieved studies
were also reviewed to identify additional literature that was
not indexed in Pubmed.
2.4. Inclusion and exclusion criteria of literature
Studies included in the study met the following criteria:
case–control study design, focused on association between
MTHFR polymorphism (C677T or A1298C or both) andpolymorphism under assumption of recessive model.
The risk of MTHFR gene polymorphisms with Down syndrome pregnancies 91DS pregnancies, published data should contain genotype fre-
quencies of polymorphism. The excluded studies were of non
case–control study design, articles in language other than
English, publications with insufﬁcient data and the following
literature type meta-analysis, review, editorial and
commentary.
2.5. Data extraction
Two authors independently extracted data from the published
literature using a standard format. Each study was looked for
the ﬁrst author, year of publication, country, study design,Figure 2 Results from meta-analysis of MTHFR C677Tnumber of cases and controls, and genotype frequencies of
studied polymorphism. Any disagreement in evaluation was
resolved by discussion.
2.6. Statistical analysis
Initially Data were manually fed in Microsoft Excel followed
by statistical analysis. The pooled ORs were performed for
dominant model and recessive model. The potential for publi-
cation bias was tested by a Begg’s test (funnel plot method)
and heterogeneity assumption was evaluated by a chi-square
based Q-test. All the above analysis was performed withpolymorphism under assumption of dominant model.
92 S. Muthuswamy, S. AgarwalReview Manager 5.2 (Review Manager (RevMan) Version 5.2.
Copenhagen: The Nordic Cochrane Centre, the Cochrane
Collaboration, 2008). Departure from the Hardy–Weinberg
equilibrium (HWE) for the C677T genotype distribution of
the MTHFR gene both in the case and control groups was
tested by chi square analysis with exact probability, and
p< 0.05 was considered as departure from HWE. A subgroup
analysis was carried out based on country of publication, India
and other countries.3. Results
3.1. Prevalence of MTHFR polymorphisms
The frequencies of the CC, CT, and TT genotypes among the
cases were 51.8%, 48.2%, and 0%, respectively. The corre-
sponding frequencies among the controls were 72.7% (CC),
27.2% (CT), and 0% (TT) (Table 1). These data indicated that
the risk of having a child with DS was 2.48 fold higher in moth-
ers with the 677C? T substitution than in mothers without the
T substitution (OR 2.48 [1.37–4.5], P= 0.0025).
Concerning the frequencies of A1298C polymorphism
variants, AA, AC and CC genotypes among the cases were
36.8%, 50.5% and 12.7%, respectively. In the control cohort
it was found as 48.2% (AA), 45.5% (AC) and 6.3% (CC)
(Table 1). Mothers who had a MTHFR AC or CC genotype
had a 1.60-fold increased risk of having a child with DS com-
pared with those who had AA genotype (OR 1.60 [0.89 to
2.83], P= 0.11). When the data were analyzed in the domi-
nant model, mothers carrying CC genotype have a 2.12-
fold, 0.5 increased risk compared to recessive model,
increased risk compared with AA or AC genotype (OR
2.12 [0.79 to 5.78] P= 0.13).Figure 3 Funnel plot analysis for publication biaThe Hardy–Weinberg equilibrium analysis of the control
cohort implied that the frequencies of C677T and A1298C geno-
type were randomly distributed (P= 0.097 and P= 0.28). In
sum, these data indicate that the presence of either the 677C?
TMTHFR polymorphism or A1298C polymorphism on one or
both alleles increased the risk of having a child with DS.
4. Meta-analysis
4.1. Characteristics of studies
The literature search identiﬁed 88 potential relevant articles.
Twenty-nine articles were excluded after initial screening.
The remaining 59 studies were further reviewed by reading
the full text, and 29 additional articles were excluded due to
study design and study subjects. Finally out of 30 studies, 3
studies in Chinese language were excluded due to non-
availability of literature in English version. Distribution of
data in the included studies is shown in Table 2.
4.2. Quantitative data synthesis
4.2.1. C677T polymorphism
The estimated polled OR was 1.26 (95% CI: 1.05–1.50,
P= 0.01) and 1.32 (95% CI: 1.19–1.47, P=<1  105) with
respect to recessive and dominant model (Table 3). In sub-
group analysis by source of study subjects, studies from other
than Indian population showed a signiﬁcant association with
OR’s of 1.25 (95% CI: 1.05–1.50, P= 0.01) in recessive model
(Table 3). The dominant model based analysis showed associ-
ation in both the subgroups (Other studies: 1.31 (95% CI:
1.17–1.46, p = 0.01) and Indian studies: 1.44 (95% CI: 1.07–
1.95, p= 0.02) (Table 3, Figs. 1 and 2).s with studies related to C677T polymorphism.
The risk of MTHFR gene polymorphisms with Down syndrome pregnancies 93We performed sensitivity analysis to evaluate the stability
of the meta-analysis. The statistical signiﬁcance of the result
was not altered when a single study was omitted, which is
not in HWE. The funnel plot revealed only a very mild asym-
metry (Fig. 3).
4.2.2. A1298C polymorphism
Nineteen studies identiﬁed the association between A1298C
polymorphism and DS pregnancy risk. A total of 1834 cases
and 2305 controls were included in this meta-analysis. Under
the assumption of recessive model, the pooled OR was 1.34
(95% CI: 1.04–1.72, P= 0.02) while assumption of dominantFigure 4 Results from meta-analysis of MTHFR A1298Cmodel resulted in no association (OR: 1.04 [0.92–1.18],
P= 0.53). However, subgroup analysis of dominant model
showed 1.46 fold increased risk of DS pregnancies among
the Indian subjects with AC and CC genotype compared with
AA genotype subjects (OR: 1.46 [0.99–2.14], P= 0.05). Simi-
larly, in recessive model Indian population showed 1.75 times
increased risk of DS pregnancy (OR: 1.75 [1.0–3.07], P= 0.54)
(Table 3, Figs. 4 and 5).
In the sensitivity analysis, we found that there was no sub-
stantial modiﬁcation of our estimate after exclusion of 6 stud-
ies whose data are not in HWE. The shape of the funnel plot
did not reveal evidence of asymmetry (Fig. 6).polymorphism under assumption of recessive model.
Figure 5 Results from meta-analysis of MTHFR A1298C polymorphism under assumption of dominant model.
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The present study examined the association of C677T and
A1298C polymorphisms with DS pregnancies and a meta-
analysis of all published literature. Since the sample size of
most of the published studies was smaller, results from such
individual study would result in false-negative or false-
positive association. Therefore, meta-analysis will provide
results based on a huge accumulated data to detect signiﬁcant
differences.
In cohorts of case (87) can controls (110) C677T and
A1298C polymorphism were studied by PCR-RFLP method.
It was observed that CT heterozygous genotype carrier moth-ers were at 2.48 fold risk of having DS child. Female’s positive
for CC genotype of A1298C polymorphism had a risk of 1.6
fold under the recessive model assumption but in the dominant
model it was elevated to 2.12 fold risk of having DS child.
In the meta-analysis, the effect of C677T and A1298C poly-
morphisms was analyzed in assumption of both recessive and
dominant models. In our results, the combined evidence sug-
gests that C677T polymorphism is signiﬁcantly associated with
the risk of DS pregnancy. A1298C polymorphism showed a
signiﬁcant risk in recessive model while in the dominant model
only India population had a risk with marginal signiﬁcance
similar to previous reports [28–30]. No association or marginal
association of A1298C polymorphism in other populations as
Figure 6 Funnel plot analysis for publication bias with studies related to A1298C polymorphism.
The risk of MTHFR gene polymorphisms with Down syndrome pregnancies 95well as in Indian population can be speculated because of 68%
retention of enzyme activity compared to 50% enzyme activity
in C677T polymorphism [16,17]. Since we didn’t measure
folate levels in the present study, a conclusion can be derived
after performing a large scale study with serum folate levels.
Also, other confounding factors should be controlled.
Our meta-analysis has also showed signiﬁcant interstudy
heterogeneity in the dominant model of C677T polymorphism
and the recessive model of A1298C polymorphism. Various
confounding factors, such as population stratiﬁcation, covari-
ates and deviation from Hardy–Weinberg equilibrium, could
be the source of heterogeneity. Therefore, we did sensitivity
analysis by excluding the studies that are not in HWE and
did not ﬁnd any contribution of such study in heterogeneity.
The funnel plot analysis revealed no publication bias.
Some limitation in our meta-analysis should be mentioned:
the effect of gene-gene or gene-environment interaction, other
gene in folate metabolism like MTR, MTRR and RFC-1 were
not analyzed [6–10]. Other factors like maternal age and folate
supplement could also affect the pregnancy but these factors
were not considered in our analysis [4]. Three studies of Chi-
nese population were also eliminated due to the non-
availability of the literature in English. Taken together, our
study suggested that both C677T and A1298C polymorphisms
were signiﬁcantly associated with the risk of DS pregnancy.Funding
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